BioCentury | Jul 13, 2016
Company News

Merck doubling down on biotech hubs

Merck & Co. Inc. (NYSE:MRK) plans to reduce its workforce by undisclosed amounts at its Kenilworth, N.J., and Rahway, N.J., sites, as well as its North Wales, Pa., screening facility. The company said the moves...
BioCentury | May 30, 2011
Company News

Lab21, Myconostica deal

Lab21 Ltd. , Cambridge, U.K. Myconostica Ltd. , Manchester, U.K. Business: Diagnostic Lab21 acquired fungal diagnostics company Myconostica for an undisclosed sum. Myconostica markets three products with CE Mark approval in Canada, Southern Africa and Europe: MycAssay...
BioCentury | Mar 1, 2010
Company News

Alliance Pharma, Cambridge Laboratories deal

...to £2.1 million ($3.2 million) (see BioCentury, Feb. 15). Alliance Pharma plc (LSE:APH), Chippenham, U.K. Cambridge Laboratories Ltd....
BioCentury | Feb 15, 2010
Company News

Alliance Pharma, Cambridge Laboratories deal

...with the company's strategy of acquiring low-risk, established products. Alliance Pharma plc (LSE:APH), Chippenham, U.K. Cambridge Laboratories Ltd....
BioCentury | Feb 15, 2010
Finance

Regulatory milestones

...plc (LSE:APH) was up 4p (15%) to 30.25p on Monday's news it plans to acquire Cambridge Laboratories Ltd....
BioCentury | Feb 9, 2010
Company News

Alliance Pharma to acquire Cambridge Labs

...Specialty pharmaceutical company Alliance Pharma plc (LSE:APH) plans to acquire Cambridge Laboratories Ltd. (Dublin, Ireland) for up to...
BioCentury | Sep 17, 2009
Distillery Therapeutics

Indication: Neurology

...deliverability in vivo. Nitoman, a selective inhibitor of vesicular monoamine transporter 2 (VMAT2; SLC18A2) from Cambridge Laboratories Ltd....
BioCentury | Jul 13, 2009
Company News

LifeHealth, NeuronIcon, Lundbeck deal

...Biovail Corp. (TSX:BVF; NYSE:BVF, Mississauga, Ontario) last year. Prestwick had U.S. and Canadian rights from Cambridge Laboratories Ltd....
BioCentury | Jun 29, 2009
Company News

Biovail, Cambridge Laboratories sales and marketing update

...two tranches over two years (see BioCentury, May 25). Biovail Corp. (TSX:BVF; NYSE:BVF), Mississauga, Ontario Cambridge Laboratories Ltd....
BioCentury | May 25, 2009
Company News

Biovail, Cambridge Laboratories, GlaxoSmithKline sales and marketing update

...from GlaxoSmithKline for $510 million (see BioCentury, May 11). Biovail Corp. (TSX:BVF; NYSE:BVF), Mississauga, Ontario Cambridge Laboratories Ltd....
Items per page:
1 - 10 of 57
BioCentury | Jul 13, 2016
Company News

Merck doubling down on biotech hubs

Merck & Co. Inc. (NYSE:MRK) plans to reduce its workforce by undisclosed amounts at its Kenilworth, N.J., and Rahway, N.J., sites, as well as its North Wales, Pa., screening facility. The company said the moves...
BioCentury | May 30, 2011
Company News

Lab21, Myconostica deal

Lab21 Ltd. , Cambridge, U.K. Myconostica Ltd. , Manchester, U.K. Business: Diagnostic Lab21 acquired fungal diagnostics company Myconostica for an undisclosed sum. Myconostica markets three products with CE Mark approval in Canada, Southern Africa and Europe: MycAssay...
BioCentury | Mar 1, 2010
Company News

Alliance Pharma, Cambridge Laboratories deal

...to £2.1 million ($3.2 million) (see BioCentury, Feb. 15). Alliance Pharma plc (LSE:APH), Chippenham, U.K. Cambridge Laboratories Ltd....
BioCentury | Feb 15, 2010
Company News

Alliance Pharma, Cambridge Laboratories deal

...with the company's strategy of acquiring low-risk, established products. Alliance Pharma plc (LSE:APH), Chippenham, U.K. Cambridge Laboratories Ltd....
BioCentury | Feb 15, 2010
Finance

Regulatory milestones

...plc (LSE:APH) was up 4p (15%) to 30.25p on Monday's news it plans to acquire Cambridge Laboratories Ltd....
BioCentury | Feb 9, 2010
Company News

Alliance Pharma to acquire Cambridge Labs

...Specialty pharmaceutical company Alliance Pharma plc (LSE:APH) plans to acquire Cambridge Laboratories Ltd. (Dublin, Ireland) for up to...
BioCentury | Sep 17, 2009
Distillery Therapeutics

Indication: Neurology

...deliverability in vivo. Nitoman, a selective inhibitor of vesicular monoamine transporter 2 (VMAT2; SLC18A2) from Cambridge Laboratories Ltd....
BioCentury | Jul 13, 2009
Company News

LifeHealth, NeuronIcon, Lundbeck deal

...Biovail Corp. (TSX:BVF; NYSE:BVF, Mississauga, Ontario) last year. Prestwick had U.S. and Canadian rights from Cambridge Laboratories Ltd....
BioCentury | Jun 29, 2009
Company News

Biovail, Cambridge Laboratories sales and marketing update

...two tranches over two years (see BioCentury, May 25). Biovail Corp. (TSX:BVF; NYSE:BVF), Mississauga, Ontario Cambridge Laboratories Ltd....
BioCentury | May 25, 2009
Company News

Biovail, Cambridge Laboratories, GlaxoSmithKline sales and marketing update

...from GlaxoSmithKline for $510 million (see BioCentury, May 11). Biovail Corp. (TSX:BVF; NYSE:BVF), Mississauga, Ontario Cambridge Laboratories Ltd....
Items per page:
1 - 10 of 57